Accutane Side Effects May Double Risk of Pink Eye, Other Eye Problems
New research has linked side effects of Accutane and the generic equivalents of the popular acne drug to an increased risk of various eye problems, including pink eye, styes and chronic dryness.
In a study published this week in the Archives of Dermatology, researchers looked at data on 14,682 Israeli adolescents and young adults who were new users of Accutane and other isotretinoin-based drugs.
According to the findings, eye problems from Accutane occurred in nearly 14% of the children who took the drugs.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Some of the risk seems to be tied to acne itself, as children who did not take the drug, but still had significant acne problems, were diagnosed with eye problems 9.6% of the time, compared to only 7.1% of children who neither took the drugs nor had acne problems.
Researchers found that the strongest association appeared to be with conjunctivitis, commonly referred to as pink eye, and concluded that Accutane may be associated with short-term ocular events, which health care professionals should consider when prescribing acne treatments.
Accutane (isotretinoin) has been used by more than 16 million people worldwide since it was first introduced by Roche in the early 1980s as a treatment for severe acne.
Roche discontinued Accutane in June 2009, due to the increasing costs associated with the litigation over Accutane side effects, which have previously been linked to a risk of inflamatory bowel disease, ulcerative colitis and Crohn’s disease. However, a number of generic versions of Accutane remain available under names such as Claravis, Sotret, Amnesteem and generic isotretinoin.
More than 7,000 Accutane lawsuits are currently pending against manufacturers of the drug. All of the complaints involve similar allegations that the popular acne drug carried inadequate warnings about the risk of bowel problems, which could develop years after the medication is used.
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.